CapForce IBD 50 ETF
FFTY
83 hedge funds and large institutions have $116M invested in CapForce IBD 50 ETF in 2019 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 24 increasing their positions, 21 reducing their positions, and 14 closing their positions.
14% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 21
7% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 14
2.28% less ownership
Funds ownership: 30.29% → 28.01% (-2.3%)
3% less funds holding
Funds holding: 86 → 83 (-3)
16% less capital invested
Capital invested by funds: $138M → $116M (-$21.5M)
Top Buyers
Top Sellers
FFTY Hedge Fund Activity: Q2 2019 in Review
83 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in CapForce IBD 50 ETF (FFTY) for Q2 2019, worth a combined $116M — down 16% from $138M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of FFTY and 13 opened new positions — a net loss of 1 holder — while 21 trimmed existing stakes and 24 added.
The largest buyer was Sigma Planning Corp, adding an estimated $2.03M. The largest seller was Wells Fargo, cutting an estimated $9.05M.
- 83 institutional investors held CapForce IBD 50 ETF (FFTY) as of Q2 2019, down from 86 in Q1 2019.
- Funds reported $116M of CapForce IBD 50 ETF stock for Q2 2019, down 16% quarter-over-quarter.
- 13 funds opened new CapForce IBD 50 ETF positions in Q2 2019 and 14 closed out, a net change of -1 holder.
- The largest CapForce IBD 50 ETF buyer in Q2 2019 was Sigma Planning Corp, an estimated $2.03M added.
- The largest CapForce IBD 50 ETF seller in Q2 2019 was Wells Fargo, an estimated $9.05M sold.
Based on aggregated 13F filings for Q2 2019.